EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
94 hedge funds and large institutions have $187M invested in Eiger BioPharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 47 increasing their positions, 17 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 17
Holders
94
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$2.94M | |
| 2 | +$2.81M | |
| 3 | +$2.53M | |
| 4 |
Goldman Sachs
New York
|
+$2.26M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$2.06M |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$1.84M | |
| 3 | -$1.33M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.11M |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$576K |